Ana Isabel Farfán‐Sedano

Author

Hospital Universitari Germans Trias i Pujol ORCID

Also Known As

A. Farfán Sedano, A. I. Farfán Sedano, A.I. Farfán Sedano, A.I. Farfán-Sedano, AI Farfán‐Sedano, Ana Farfán Sedano, Ana I Farfán Sedano, Ana I. Farfán-Sedano, Ana I. Farfán‐Sedano, Ana Isabel Farfán-Sedano

Publications

417

Citations

H-Index

Concepts

All Affiliations

Hospital Universitari Germans Trias i Pujol Universidad de Alcalá Brigham and Women's Hospital Hospital Universitario de Fuenlabrada Universitat Autònoma de Barcelona

About

Ana Isabel Farfán‐Sedano is an author at Hospital Universitari Germans Trias i Pujol specializing in medicine, public health, and patient safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	107
2	Public Health	2	2	54
3	Emergency Medicine	2	2	89
4	Epidemiology	1	1	18
5	Geriatrics	1	1	18

Ana Isabel Farfán‐Sedano

Publications

143

Citations

H-Index

Page 1

	Year	Citations
Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis Pablo Demelo‐Rodríguez, Ana Isabel Farfán‐Sedano, José María Pedrajas, Journal of Thrombosis and Haemostasis ThrombosisHematologyPatient SafetyTherapeutic DosesCoagulopathy	2021	53
Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism Ana Jaureguízar Oriol, David Jiménez, Behnood Bikdeli, CHEST Journal ThrombosisPulmonary EmbolismHeart RateCardiovascular DiseasePatient Safety	2021	36
Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID‐19 patients Miguel Ángel Duarte‐Millán, Nieves Mesa‐Plaza, M. Guerrero-Santillán, Journal of Medical Virology Prognostic FactorsSpanish CohortElderly PatientsLasso Regression ModelPrognosis	2021	18
Baricitinib or imatinib in hospitalized COVID‐19 patients: Results from COVINIB, an exploratory randomized clinical trial Alejandro Morales‐Ortega, Ana Isabel Farfán‐Sedano, Juan San Martín, Journal of Medical Virology	2023	13
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism Behnood Bikdeli, David Jiménez, J. del Toro, Journal of the American Heart Association	2021	12
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study Javier Trujillo‐Santos, Dominique Farge, José María Pedrajas, Research and Practice in Thrombosis and Haemostasis	2022	11

Page 1